Table 1.
Target group for LTBI screening in the Netherlands | Number eligible for LTBI screening | Number screened for LTBI | Screening coverage | Number LTBI cases diagnosed and reported to NTR | Number cases that initiated LTBI treatment | LTBI treatment coverage | Number completed LTBI treatment (2014) | LTBI completion rate (2014) | Number with active TB reported to NTR | TB incidence among target group (per 100,000) |
---|---|---|---|---|---|---|---|---|---|---|
All contacts of TB patients | * | * | * | 867 | 679 | 78% | 505/575 | 88% | 65 | |
People living with HIV | 865 ‡ | Unknown | – | 3 | 3 | 100% | 4/4 | 100% | 36 | |
Patients initiating / on TNF-alpha blocking treatment | Unknown | Unknown | – | 192** | 177** | 92% | 151/169** | 89% | 14 | |
Patients preparing for (or with) organ or hematologic transplantation | Unknown | Unknown | – | 5 | ||||||
Health care workers | Unknown | Unknown | – | 21 | 17 | 81% | 27/29 | 93% | 6 | |
Travelers | Unknown | Unknown | – | 22 | 18 | 82% | 20/20 | 100% | ||
Others*** | Unknown | Unknown | – | 328 | 234 | 79% | 194/216 | 90% | ||
Total | Unknown | Unknown | – | 1433 | 1128 | 79% | 901/1013 | 89% |
Note: There is no policy in the Netherlands to screen patients with renal insufficiency/ dialysis or with silicosis for LTBI.
LTBI: latent tuberculosis infection; NTR: Netherlands Tuberculosis Register; TB: tuberculosis.
Data is available of the number of contacts eligible for TB examination in source tracing and contact investigation (n= 7162) related to a TB patient diagnosed in 2014, the number of contacts actually screened for LTBI (n= 5446) and the screening coverage (76%). The dataset allows a breakdown in intensity of contacts, i.e. household and close contacts, but not (yet) for age group, such as children.
LTBI screening data in the NTR has been combined for patients initiating TNF-alpha blocking therapy and preparing for transplantation.
Others: mainly pre-employment, pre-travel and other low-risk LTBI screening.